About the Schiff Center
Mission Statement: To cure liver disease through innovative research, effective treatment and expert medical education.
Welcome to the Schiff Center for Liver Diseases at the University of Miami Miller School of Medicine, one of the premier hepatology research institutions. We are focused on developing treatments and cures for cirrhosis, hepatitis B, C, D, E and liver and biliary tract diseases as a whole.
At the Schiff Center for Liver Diseases, we are dedicated to providing our patients with compassionate care while pursuing the most challenging problems in hepatology. Through our research in basic science, academic inquiry and clinical trials, we hope to benefit the health of our patients and improve the state of liver diseases in society at large.
The Schiff Center for Liver Diseases experienced another exciting year of breakthroughs. Our contributions towards curing HCV have been monumental. The focus now is on more effective screening for undiagnosed cases and monitoring for hepatocellular carcinoma (liver cancer) among those who have been cured but have underlying cirrhosis of the liver.
Clearly the most important challenge in liver disease over the next decade is finding drugs that are safe and effective for non-alcoholic steatohepatitis (NASH). We are involved in 55 clinical trials assessing new therapeutic agents for NASH. Many of these compounds also have promise in stopping fibrosis in the liver. Some of the new studies will focus on chronic cholestatic liver disease which includes primary biliary cholangitis and primary sclerosing cholangitis.
On this site, you will find information about the areas of research that we are currently involved in, how to get in contact with our staff, and ways that you can help further our cause.